FIELD: biotechnology, medicine. SUBSTANCE: strain is prepared by prolonged mass selection (262 cycles) to increase metastatic potential and accelerate metastasis rate formation on the basis of rhabdomyosarcoma strain showing affinity for PA-2. Strain is passaged in white mongrel rats by intravenous administration of single cells suspension after 17-19 days. Strain shows high metastatic activity, rapid formation and growth of pulmonary metastasis, the presence of marker protein p58-receptor of cell surface which is necessary for realization of tumor cell capability to metastasis. EFFECT: improved properties of strain proposed. 1 dwg
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF RAT RABDOMYOSARCOME RA-22 CELLS, USED FOR FEATURE TUMORS DETECTION, RESISTANT TO HYPERTHERMIA TREATMENT | 0 |
|
SU1751201A1 |
METHOD OF SELECTION OF CELL POPULATION IN VIVO | 1995 |
|
RU2111249C1 |
METHOD OF SELECTION OF CELL POPULATION IN VIVO | 0 |
|
SU1806195A3 |
AGENT FOR CORRECTION OF CYTOSTATIC POLYCHEMOTHERAPY WITH ANTI-INFLAMMATORY ACTIVITY | 2010 |
|
RU2425680C1 |
METHOD FOR MURINE MELANOMA LYMPHATIC AND HEMATOGENOUS METASTASIS B SIMULATION FOR NONLINEAR WHITE RATS | 2016 |
|
RU2615908C1 |
CORRECTOR OF CYTOSTATIC POLYCHEMOTHERAPY | 2007 |
|
RU2353623C1 |
METHOD FOR REDUCING MULTI-DRUG RESISTANCE WITH USING INOSITOL TRIPYROPHOSPHATE | 2010 |
|
RU2563127C2 |
AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
RECOMBINANT HUMAN BREAST CANCER CELL LINE BRCCH4E-134, EXPRESSING HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN | 2019 |
|
RU2726541C1 |
ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
Authors
Dates
1995-01-09—Published
1991-06-26—Filed